GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13DA1

Company

Addex Therapeutics Ltd.

Filed

January 10, 2022

Accession Number

0001072613-22-000026